Aromataz inhibitörü kullanan erken evre meme kanserli hastalarda osteoporoz gelişme riski

Erbağ, Gökhan

dc.contributor.advisor	Uygun, Kazım
dc.contributor.author	Erbağ, Gökhan
dc.date.accessioned	2022-03-04T10:54:06Z
dc.date.available	2022-03-04T10:54:06Z
dc.date.issued	2011
dc.identifier.other	452777
dc.identifier.uri	http://dspace.kocaeli.edu.tr:8080/xmlui/handle/11493/13009
dc.language.iso	tur
dc.publisher	Kocaeli Üniversitesi, Tıp Fakültesi
dc.rights	openAccess
dc.subject	Onkoloji
dc.subject	Oncology
dc.subject	Ortopedi ve Travmatoloji
dc.subject	Orthopedics and Traumatology
dc.title	Aromataz inhibitörü kullanan erken evre meme kanserli hastalarda osteoporoz gelişme riski
dc.title.alternative	The risk of developing osteoporosis of the early-stage breast cancer patients using aromatase inhibitor
dc.type	specialtyThesis
dc.contributor.department	İç Hastalıkları Ana Bilim Dalı
dc.identifier.endpage	49